[MDR (Multiple Drug Resistant) type of resistance to chemotherapy in clinical practice].

Abstract:

:Multifactorial resistance is the main mechanism of chemotherapy failure in cancers. Multidrug resistance (MDR) is related to the expression of a 170 kDa membrane glycoprotein, the so-called P-glycoprotein (P-gp). This protein is able to extrude drugs of various structures and mechanisms out of the cytoplasm. P-gp is a pronostic value in hemopathy as well as in child sarcoma, osteosarcoma and neuroblastoma. Modulator agents of different generations are capable of inhibiting P-gp. MDR modulation is obtained in hemopathies and is associated with an eradication of the P-gp (+) cell clones. In solid tumors, clinical trials using verapamil or cyclosporin are not so convincing. It is likely that other mechanisms of resistance are responsible for tumor progression, such as the MRP system, glutathion and topoisomerases. A better knowledge of multifactorial resistance and drug synthesis counteracting these resistance mechanisms will allow to elaborate new therapeutic basis for cancer therapy.

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Oudard S,Marie JP,Pujade Lauraine E

subject

Has Abstract

pub_date

1996-08-01 00:00:00

pages

609-18

issue

8

eissn

0007-4551

issn

1769-6917

journal_volume

83

pub_type

杂志文章,评审
  • [Symptomatic management of brain metastasis].

    abstract::Indications and choice of antiepileptic drugs (AED), treatments for cerebral edema and prophylactic and curative treatments of thromboembolic complications of brain metastasis are discussed. ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2012.1689

    authors: Le Rhun E,Taillandier L,Beauchene P,Bailon O,Dubois F

    更新日期:2013-01-01 00:00:00

  • [End of chemotherapy decision for metastatic breast cancer patients.].

    abstract::If chemotherapy beyond the third line often gives sum clinical benefits, it is sometimes prescribed only to avoid telling bad news to patients. Palliative chemotherapy can lead to symptom reduction and greater health related quality-of-live, but longer survival is unlikely. Physician's questioning about chemotherapy c...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2009.0895

    authors: Bouleuc C,Chvetzoff G

    更新日期:2009-09-01 00:00:00

  • [Pre-therapeutic and evolutive characteristics of patients suffering from chronic myeloid leukemia, in Abidjan, Ivory Coast].

    abstract:INTRODUCTION:The diagnosis of chronic myeloid leukemia is based on the presence of translocation t(9,22). Additional cytogenetic abnormalities may exist at diagnosis and have prognostic value. The authors evaluated the relationship between these additional chromosomal abnormalities, clinical presentation, and therapeut...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2019.03.013

    authors: Silué DA,Kouakou B,Nanho CD,Kamara I,Djoko S,Sowhe T,Meité N,Ayemou R,Emeuraude N,Tolo A,Koffi G,Sanogo I

    更新日期:2019-06-01 00:00:00

  • [Acute cerebellar syndrome after treatment with 5-fluorouracil].

    abstract::We report on a case of 5-fluorouracil induced neurotoxicity during 5-fluorouracil cisplatin combination chemotherapy for advanced head and neck squamous cell carcinoma. The initial manifestations included an acute cerebellar syndrome and peripheral neuropathy. Computed tomography of the brain was normal. The results o...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Barbieux C,Patri B,Cerf I,de Parades V

    更新日期:1996-01-01 00:00:00

  • [Angiogenin: involvement in angiogenesis and tumour growth].

    abstract::Angiogenin is one of the most potent inducers of neovascularization in experimental models in vivo. Angiogenin is normally present in plasma but overexpressed in cancer patients. The possible involvement of angiogenin in the development of cancer is suggested by its overexpression in patients with a variety of tumours...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Pavlov N,Badet J

    更新日期:2001-08-01 00:00:00

  • [Results of a combination of platinum-vindesin-ametycin-bleomycin (CEMB) in the treatment of stage IV non-small-cell lung cancers].

    abstract::From July 1987 to July 1988, 35 patients with non small cell lung cancer, stage IV, were included in a phase II trial (GLOT NPC 87/01). The treatment was as follows: cisplatin 50 mg/m2 day 1, vindesin 3 mg/m2 day 1, mitomycin 6 mg/m2 day 2, and bleomycin 15 mg/day, day 1 + 2 by continuous infusion. The evaluation for ...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Souquet PJ,Fournel P,Jorda M,Laennec E,Piperno D,Trillet V,Rebattu P,Bernard JP

    更新日期:1993-01-01 00:00:00

  • [Cytotoxicity of tamoxifen and its principal metabolites in human breast cancer cell lines].

    abstract::The antiestrogen tamoxifen (TAM) has been successfully used to treat breast cancer expressing estrogen and progesterone receptors (ER+ and PR+). However, the development of antiestrogen resistance is frequently observed in patients following long-term treatment. To better understand the mechanism of action of TAM and ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Bachmann-Moisson N,Barberi-Heyob M,Merlin JL,Ledrich ML,Batt AM,Guillemin F

    更新日期:1996-10-01 00:00:00

  • [Tumor-stroma interactions].

    abstract::It is widely accepted that the development of carcinoma is not only due to somatic mutations in epithelial cells but also is influenced by the tumor microenvironment ie the stroma. The different stroma components produced growth factors, cytokines, the extra cellular matrix and also participated to the recruitment of ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2008.0560

    authors: Billottet C,Jouanneau J

    更新日期:2008-01-01 00:00:00

  • [Gemcitabine and pemetrexed in genito-urinary tumors treatment].

    abstract::Among genito-urinary tumors, gemcitabine is indicated only for the treatment of locally advanced and metastatic urothelial cancer. The combination of gemcitabine and cisplatin is a new standard in this disease. Gemcitabine shows activity in refractory germ cell tumors. In salvage treatment its role is ongoing evaluati...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Fléchon A

    更新日期:2007-01-01 00:00:00

  • [Percutaneous ablation of metastases: where are we and new techniques].

    abstract::When a metastatic disease is localized and slowly evolving either spontaneously or after a general treatment, a local treatment may be proposed. For about 15 years, image-guided percutaneous ablation has been developed which allows to treat tumors with temperature modifications. These mini-invasive techniques may be r...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2013.1728

    authors: Palussière J,Buy X,Fonck M

    更新日期:2013-04-01 00:00:00

  • Altered glucose metabolism in intact and tumor bearing rats subjected to local hyperthermia.

    abstract::Blood glucose levels were temporarily elevated in normal and in tumor bearing Lewis rats subjected to one local hyperthermic treatment in the leg or in the upper abdomen. Serum transferred from locally heated animals or serum heated in-vitro and injected to normal recipients resulted in elevated blood glucose levels. ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Beer-Gabel M,Yerushalmi A

    更新日期:1981-01-01 00:00:00

  • [SOR SAVOIR PATIENT Cancer and fatigue. Information dedicated to cancer patients and relatives].

    abstract::In response to the evolution of the information-seeking behaviour of patients and concerns from health professionals regarding cancer patient information, the French National Federation of Comprehensive Cancer Centres (FNCLCC) introduced, in 1998, an information and education program dedicated to patients and relative...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Dielenseger P,Dilhuydy JM,Brusco S,Chazot L,Blay JY,Bové B,Colcanap B,Ferrandez JC,Floquet A,Jane Gledhill,Hubert N,Meslier M,Rosman S,Carretier J,Delavigne V,Fervers B,Leichtnam-Dugarin L,Philip T,Standards, Options

    更新日期:2006-12-01 00:00:00

  • [Cancer of the uterine cervix in young women. A retrospective study of 337 cases].

    abstract::A retrospective study of 337 cases of cervix cancers in women aged 35 years and under, treated between 1980-1990 at the Ibn Rochd Oncology Center in Casablanca, was analyzed in order to determine the main characteristics of this disease and the influence of age on prognosis. The incidence of these cases was stable thr...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Acharki A,Sahraoui S,Benider A,Tawfiq N,Jouhadi H,Bouras N,Samlali R,Kahlain A

    更新日期:1997-04-01 00:00:00

  • [Carcinoma of the nasopharynx (cavum) : clinical and developmental aspects].

    abstract::Between 1959 and 1974, two hundred and ninety six carcinomas of the nasopharynx were seen at the Institut Gustave-Roussy, in adults. 78% were in man. The most frequently encountered were undifferentiated or poorly differentiated forms, 76% of cases. 38% only of the patients had their birthplace in France. On the first...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Brugère J,Eschwege F,Schwaab G,Micheau C,Cachin Y

    更新日期:1975-07-01 00:00:00

  • [Impact of radiotherapy on female fertility].

    abstract::Radiation therapy may have deleterious effects on female fertility. It can cause ovarian dysfunction, uterine damages or disrupt the hypothalamic-pituitary axis. These effects occur at varying dose levels usually relatively low compared to the prescribed doses. Other co-factors influence the effects of radiation thera...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2015.03.015

    authors: Mazeron R,Maroun P,Cao K,Mbagui R,Slocker-Escarpa A,Chargari C,Haie-Meder C

    更新日期:2015-05-01 00:00:00

  • [Gemcitabine and breast cancer].

    abstract::Gemcitabine has demonstrated a good efficacy in number of tumor types. Thanks to its favourable toxicity profile, gemcitabine can be used in combination with a number of drugs. Single agent gemcitabine and gemcitabine-based combinations have been evaluated in metastatic breast cancer. Some of these combinations, such ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Besse B,Spano JP

    更新日期:2002-08-01 00:00:00

  • [Renal toxicity of contrast agents in oncologic patients].

    abstract::Cancer patients frequently undergo imaging examinations to diagnosis but also to evaluate their responses to treatment. These patients are also at high risk of kidney impairment before considering the possible nephrotoxicity of their chemotherapy. In this context, it is overriding to know contrast agents induced risks...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2011.1477

    authors: Amet S,Deray G

    更新日期:2012-03-01 00:00:00

  • [Oxaliplatin in combination with 5-fluoro-uracil and folinic acid as treatment of metastatic colorectal cancer].

    abstract::Unusual aspect of the development of oxaliplatin was that substantial evidence of its activity was gathered when used in combination with protracted infusion of 5FU combined with leucovorin, preceeding the formal demonstration of its single activity in this disease. Phase II trials in previously treated patients by 5F...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: André T,Louvet C,Maindrault-Goebel F,Gramont AD

    更新日期:2001-08-01 00:00:00

  • [Intraoral minor salivary gland tumors. Report of 296 cases (author's transl)].

    abstract::296 intraoral minor salivary gland tumors were observed among 702 salivary tumors. The study emphasizes a frequent palatine location, observed in more than 50 per cent of theses tumors. Pleiomorphic adenomas (or so called mixed tumors), are frequently encountered; but it is noteworthy that the proportion of muco-epide...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Brocheriou C,Crepy C,Guilbert F,Lartigau G,Payen J,Recoing J

    更新日期:1980-01-01 00:00:00

  • [What are the expectations of coordination and accompaniment of French patients with cancer towards their community pharmacist?]

    abstract:PURPOSES:Analyze the relationship and expectations of cancer patients towards the community pharmacist in a pharmaceutical care coordination project. METHODS:In November 2014, a questionnaire was distributed to ambulatory patients of a university hospital specialized in oncology. Thirteen questions explored the consum...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2017.11.017

    authors: Hébert G,Minvielle E,Di Palma M,Lemare F

    更新日期:2018-03-01 00:00:00

  • Putative role of antioxidant enzymes and glyoxalases in carcinogenesis.

    abstract::The effects various drugs exert on antioxidant enzyme and glyoxalase activity in rat livers were studied. All drugs tested provoked a marked reduction in glutathione peroxidase and a small drop in both glyoxalase I and II activity. It is hypothesized that the substances tested support tumour development by neutralizin...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Liotti FS,Menghini AR,Guerrieri P,Mariucci G,Armellini R

    更新日期:1993-01-01 00:00:00

  • [Primary prevention of colorectal cancer].

    abstract::Results from case-control studies and prospective studies suggest that diet is involved in the causation of large bowel cancer either as initiator, promoter or inhibitor of carcinogenesis. Available data are not sufficient to serve as a basis for firm specific dietary advice. In the present situation it is attractive ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Faivre J,Couillault C,Belghiti C

    更新日期:1995-07-01 00:00:00

  • [Radiation-induced sarcoma].

    abstract::Based upon the literature, we discuss epidemiological, histopathological, clinical and treatment aspects of postirradiation sarcomas. The risk of postirradiation sarcoma is very low and negligible in comparison with the beneficial effect of radiotherapy, and it should not be a major factor influencing treatment decisi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Melhouf MM,Amrani N,Dubois JB

    更新日期:1997-09-01 00:00:00

  • Loss of efficacy of ondansetron-dexamethasone during successive courses in female patients receiving high-dose cisplatin.

    abstract::This study was designed to evaluate the efficiency of the association ondansetron-dexamethasone during successive courses in 22 chemotherapy-naive female patients receiving a chemotherapy regimen including cisplatin at a dose of 100 mg/m2. The antiemetic treatment consisted of dexamethasone 20 mg i.v. and ondansetron ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Chevalier-Evain V,Bonneterre J,Adenis A,Pion JM,Hecquet B

    更新日期:1994-03-01 00:00:00

  • [Linac-based stereotactic radiosurgery and radiotherapy].

    abstract::Stereotactic radiation therapy, consisting in irradiating the tumor with a high dose per fraction, has a therapeutic potential because of excellent local control. This technique requires a high accuracy level in order to minimize the risk of normal tissue toxicity. Initially used for cerebral localization, the stereot...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2010.1144

    authors: Ayadi M,Ginestet C,Gassa F,Claude L,Mazeron JJ

    更新日期:2010-07-01 00:00:00

  • [Response in patients with melanoma to immunization using melanoma oncolysates of vaccine virus].

    abstract::Thirty-two patients with high risk melanoma (either primary melanoma of the limbs or trunk, or recurrent melanoma) and clinically disease-free following appropriate surgical treatment were immunized with a vaccinia virus oncolysate made from a pool of 4 human melanoma cell lines. Injections were given id weekly for 3 ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Doré JF,Portoukalian J,Berthier-Vergnes O,Jacubovich R,Genève J,Bailly M,Lefthériotis E,Weissbrod A,Mayer M

    更新日期:1990-01-01 00:00:00

  • Bilateral adrenal metastases of renal cell carcinoma: a case report.

    abstract::We report a case of renal cell carcinoma presenting with bilateral adrenal masses diagnosed by ultrasonography four years after nephrectomy. The histopathological examination of the trucut biopsy specimens obtained percutaneously by ultrasound guidance revealed bilateral adrenal mestastases of renal cell carcinoma. ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Sahin A,Ozen H,Ozmen M,Remzi D

    更新日期:1994-02-01 00:00:00

  • [Irinotecan for the treatment of metastatic colorectal cancer].

    abstract::In a dozen years of development, irinotecan (CPT11) became one of major therapeutics in the taking care of the metastatic colorectal cancer (CCRM). First used in monotherapy every three weeks, irinotecan has been later developed in association with 5FU and folinic acid according to two modalities of administration (bo...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Assenat E,Duffour J,Ychou M

    更新日期:2006-05-01 00:00:00

  • [Schooling of young people with cancer].

    abstract::The schooling of young people with cancer poses various problems, similar to those experienced by disabled or chronically ill children. Published data on this subject in the medical literature comes mainly from studies carried out in the USA and the UK. Cancer and its treatment can cause both direct (learning difficul...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Vignes C,Godeau E,Bertozzi-Salamon AI,Vignes M,Grandjean H,Arnaud C

    更新日期:2007-04-01 00:00:00

  • [What do we know about ATM protein expression in breast tissue?].

    abstract::The great majority of breast cancer cases are not associated with a mutated gene of high penetrance such as BRCA1, BRCA2 and TP53. Genes of low penetrance, frequently mutated in the general population, might play an important role in breast cancer development. The ATM gene, which encodes the ATM protein, mutated in th...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Angèle S,Tanière P,Hall J

    更新日期:2001-07-01 00:00:00